Andrew John Nichols - Mar 1, 2022 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Chief Scientific Officer
Signature
/s/ Noah Clauser, as attorney-in-fact for Andrew John Nichols
Stock symbol
ATXS
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 06:18 PM
Previous filing
Jun 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (right to buy) Award $0 +55K $0.00 55K Mar 1, 2022 Common Stock 55K $6.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 1, 2022 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 17, 2022 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.